Financials of Ajanta Pharma Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Ajanta Pharma Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +8821,0211,0281,1051,0541,1451,1871,1461,1701,3031,3541,3751,422
Expenses +7327507387917768158758258739511,0269931,088
Operating Profit149271291314278330311321297351328382333
OPM %17%27%28%28%26%29%26%28%25%27%24%28%23%
Other Income +37322114362619301826592561
Interest1122216865352
Depreciation33333434343434364041434445
Profit before tax152269276291278322290307269331341359347
Tax %20%23%29%28%27%24%25%24%16%23%24%24%23%
Net Profit +122208195210203246216233225255260274267
EPS in Rs9.5416.2415.2416.3915.8219.6817.3318.6418.0320.4420.8321.9121.35

Financials of Ajanta Pharma Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +1,4741,7491,9832,1262,0552,5882,8903,3413,7434,2094,6485,453
Expenses +9681,1551,2921,4671,4891,9041,8892,4082,9343,0373,3794,058
Operating Profit5055946916585676831,0019338081,1721,2691,395
OPM %34%34%35%31%28%26%35%28%22%28%27%26%
Other Income +8142024218824112748585172
Interest6510112810672116
Depreciation524461607296116125131135144173
Profit before tax4565596486235146649009097451,1141,1891,378
Tax %32%26%22%25%25%30%27%22%21%27%23%23%
Net Profit +3104165074693874686547135888169201,056
EPS in Rs23.4731.4938.4035.5029.5635.7350.3855.6345.8963.7073.6884.52
Dividend Payout %17%17%23%0%20%24%13%11%15%79%38%0%

Financials of Ajanta Pharma Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital181818181818171725252525
Reserves8231,1731,5502,0242,2282,5812,9783,2473,3633,5423,7654,502
Borrowings +72811236753125363547260
Other Liabilities +2332072543833836197027111,1599271,0671,368
Total Liabilities1,1461,4791,8232,4262,6643,2933,7294,0004,5824,5304,9046,155
Fixed Assets +2884515891,0531,1781,4721,5411,5121,4961,4791,7621,867
CWIP17024033961262132108153209256176258
Investments60861821907879176147535349464588
Other Assets +6297037131,1221,1471,6101,9042,1882,3412,4462,5023,441
Total Assets1,1461,4791,8232,4262,6643,2933,7294,0004,5824,5304,9046,155

Financials of Ajanta Pharma Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +2793266092813754575765627927851,157529
Cash from Investing Activity +-158-209-383-256-223-224-282-74-56065-377-429
Cash from Financing Activity +-105-117-202-0-147-129-318-460-108-1,051-733-168
Net Cash Flow16-024254104-2428124-20147-68
Free Cash Flow176293131932228417431618646840169
CFO/OP84%82%110%64%87%89%81%86%117%94%117%64%

Financials of Ajanta Pharma Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days64785979821099311110310893124
Inventory Days159180186315415276434347283283308289
Days Payable109128157224214202212143147159155168
Cash Conversion Cycle11413088170282184315315240233246246
Working Capital Days5678651031131081261408311997148
ROCE %57%52%46%34%24%27%32%29%23%32%32%32%